ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
6,037.59
1.06%
US Tech 100
21,114.80
-0.33%
Dow Jones
43,325.80
0.00%
Brent Oil
73.45
0.77%
Bitcoin
96,218.27
0.56%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC

  6. Defence Therapeutics Inc (QB) (DTCFF) Quote

Defence Therapeutics Inc (QB)

Defence Therapeutics Inc (QB) (DTCFF)

USOTC
0.2732
0.00
(0.00%)
Closed December 27 4:00PM
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
0.2732
Bid
0.3131
Ask
0.5214
Volume
-
0.00 Day's Range 0.00
0.2732 52 Week Range 1.738
Market Cap
13.018M
Previous Close
0.2732
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
679
Shares Outstanding
47,650,370
Dividend Yield
-
PE Ratio
-0.98
Earnings Per Share (EPS)
-0.28
Revenue
-
Net Profit
-13.19M

About Defence Therapeutics Inc (QB)

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.defencetherapeutics.com
Headquarters
Vancouver, British Columbia, Can
Founded
-
Defence Therapeutics Inc (QB) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker DTCFF. The last closing price for Defence Therapeutics (QB) was $0.27. Over the last year, Defence Therapeutics (QB) shares have traded in a share price range of $ 0.2732 to $ 1.738.

Defence Therapeutics (QB) currently has 47,650,370 shares outstanding. The market capitalization of Defence Therapeutics (QB) is $13.02 million. Defence Therapeutics (QB) has a price to earnings ratio (PE ratio) of -0.98.

Ask ADVFN Intelligence (AI)

DTCFF Latest News

More News

DEFENCE RETAINS CATO SMS TO ADVISE ON ITS  PHASE I CLINICAL TRIAL ON ACCUTOXTM FOR BREAST CANCER

 DEFENCE RETAINS CATO SMS TO ADVISE ON ITS  PHASE I CLINICAL TRIAL ON ACCUTOXTM FOR BREAST CANCER  Vancouver, BC, Canada, February 16th, 2022 -- InvestorsHub NewsWire Defence Therapeutics Inc...

February 16 2022
InvestorsHub NewsWire

Defence's AccumTM-HPV vaccine formulation (AccuVAC-PT009) activates a 36-fold higher humoral response compared to Gardasil-9

  Defence's AccumTM-HPV vaccine formulation (AccuVAC-PT009) activates a 36-fold higher humoral response compared to Gardasil-9   Vancouver, BC, Canada, January 26th...

January 26 2022
InvestorsHub NewsWire

DEFENCE THERAPEUTICS VACCINES AND PROGRAM DEVELOPMENT

Vancouver, BC, Canada -- November 30th 2021 -- InvestorsHub NewsWire -- Defence Therapeutics Inc. (CSE: DTC; FSE: DTC; USOTC: DTCFF) ("Defence" or the...

November 30 2021
InvestorsHub NewsWire

DEFENCE THERAPEUTICS CANCER VACCINE ACCUVAC-D001 MANUFACTURING TARGETS MELANOMA AND BREAST CANCER

DEFENCE THERAPEUTICS CANCER VACCINE ACCUVAC-D001 MANUFACTURING TARGETS MELANOMA AND BREAST CANCER   Vancouver, BC, Canada -- November 23, 2021 -- InvestorsHub NewsWire...

November 23 2021
InvestorsHub NewsWire

DEFENCE THERAPEUTICS APPOINTS DR. RIAM SHAMMAA TO ITS BOARD OF DIRECTORS

 DEFENCE THERAPEUTICS APPOINTS DR. RIAM SHAMMAA TO ITS BOARD OF DIRECTORS Vancouver, BC, Canada, November 9th, 2021 -- InvestorsHub NewsWire -- Defence Therapeutics Inc. CSE:DTC, USOTC:DTCFF...

November 09 2021
InvestorsHub NewsWire

VACCINE RESULTS: DEFENCE THERAPEUTICS REPORTS SUCCESSFUL COMPLETION OF ITS COVID-19 VACCINE ACCUVAC-PT001 TOXICOLOGY STUDIES IN RABBITS

  VACCINE RESULTS: DEFENCE THERAPEUTICS REPORTS SUCCESSFUL COMPLETION OF ITS COVID-19 VACCINE ACCUVAC-PT001 TOXICOLOGY STUDIES IN RABBITS   Vancouver, BC, Canada, November...

November 03 2021
InvestorsHub NewsWire

DEFENCE THERAPEUTICS ACCUMTM VARIANTS IN VITRO STUDY INCREASES THE POTENCY OF T-DERUXTECAN ADC BY 5-FOLD ON BREAST CANCER

  DEFENCE THERAPEUTICS ACCUMTM VARIANTS IN VITRO STUDY INCREASES THE POTENCY OF T-DERUXTECAN ADC BY 5-FOLD ON BREAST CANCER   Vancouver, BC, Canada, October 13th...

October 13 2021
InvestorsHub NewsWire

DEFENCE THERAPEUTICS PREPARES FOR PHASE I TRIAL TO TEST ITS DC CANCER VACCINE, ACCUVAC-D002, AGAINST MELANOMA

    DEFENCE THERAPEUTICS PREPARES FOR PHASE I TRIAL TO TEST ITS DC CANCER VACCINE, ACCUVAC-D002, AGAINST MELANOMA Vancouver, BC, Canada, October 6th, 2021 -- InvestorsHub NewsWire -- Defence...

October 06 2021
InvestorsHub NewsWire

DEFENCE THERAPEUTICS TO FINALIZE ITS OBJECTIVES TO INITIATE A PHASE I TRIAL AGAINST BREAST CANCER

 DEFENCE THERAPEUTICS TO FINALIZE ITS OBJECTIVES TO INITIATE A PHASE I TRIAL AGAINST BREAST CANCER Vancouver, BC, Canada, September 29th, 2021 - InvestorsHub NewsWire -- Defence Therapeutics Inc...

September 29 2021
InvestorsHub NewsWire

DEFENCE THERAPEUTICS SUCCESSFULLY ENGINEERED AND TESTED A NOVEL INTRANASAL COVID-19 VACCINE FORMULATION IN ANIMALS

 DEFENCE THERAPEUTICS SUCCESSFULLY ENGINEERED AND TESTED A NOVEL INTRANASAL COVID-19 VACCINE FORMULATION IN ANIMALS Vancouver, BC, Canada, September 20th, 2021 -- InvestorsHub NewsWire -- Defence...

September 20 2021
InvestorsHub NewsWire
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
4-0.14026-33.92347506410.413460.413460.27321000.34333CS
12-0.13654-33.32357104510.409740.43610.27326790.41217026CS
26-0.3768-57.96923076920.650.66070.27329050.49045093CS
52-1.3768-83.44242424241.651.7380.27328090.80631066CS
156-3.9768-93.57176470594.254.470.273210051.75341377CS
260-2.2268-89.0722.56.40780.273211862.81663998CS

DTCFF - Frequently Asked Questions (FAQ)

What is the current Defence Therapeutics (QB) share price?
The current share price of Defence Therapeutics (QB) is $ 0.2732
How many Defence Therapeutics (QB) shares are in issue?
Defence Therapeutics (QB) has 47,650,370 shares in issue
What is the market cap of Defence Therapeutics (QB)?
The market capitalisation of Defence Therapeutics (QB) is USD 13.02M
What is the 1 year trading range for Defence Therapeutics (QB) share price?
Defence Therapeutics (QB) has traded in the range of $ 0.2732 to $ 1.738 during the past year
What is the PE ratio of Defence Therapeutics (QB)?
The price to earnings ratio of Defence Therapeutics (QB) is -0.98
What is the reporting currency for Defence Therapeutics (QB)?
Defence Therapeutics (QB) reports financial results in CAD
What is the latest annual profit for Defence Therapeutics (QB)?
The latest annual profit of Defence Therapeutics (QB) is CAD -13.19M
What is the registered address of Defence Therapeutics (QB)?
The registered address for Defence Therapeutics (QB) is 1680 - 200 BURRARD STREET, VANCOUVER, BRITISH COLUMBIA, V6C 3L6
What is the Defence Therapeutics (QB) website address?
The website address for Defence Therapeutics (QB) is www.defencetherapeutics.com
Which industry sector does Defence Therapeutics (QB) operate in?
Defence Therapeutics (QB) operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AABVFAberdeen International Inc (PK)
$ 0.027725
(0.00%)
0
AABKFAareal Bank AG (PK)
$ 0.00
(0.00%)
0
AABBAsia Broadband Inc (PK)
$ 0.02095
(0.00%)
0
AAALYAareal Bank AG (PK)
$ 34.65
(0.00%)
0
AAAIFAlternative Investment Trust (PK)
$ 0.55
(0.00%)
0
AABVFAberdeen International Inc (PK)
$ 0.027725
(0.00%)
0
AABKFAareal Bank AG (PK)
$ 0.00
(0.00%)
0
AABBAsia Broadband Inc (PK)
$ 0.02095
(0.00%)
0
AAALYAareal Bank AG (PK)
$ 34.65
(0.00%)
0
AAAIFAlternative Investment Trust (PK)
$ 0.55
(0.00%)
0
AABVFAberdeen International Inc (PK)
$ 0.027725
(0.00%)
0
AABKFAareal Bank AG (PK)
$ 0.00
(0.00%)
0
AABBAsia Broadband Inc (PK)
$ 0.02095
(0.00%)
0
AAALYAareal Bank AG (PK)
$ 34.65
(0.00%)
0
AAAIFAlternative Investment Trust (PK)
$ 0.55
(0.00%)
0

DTCFF Discussion

View Posts
Man6677 Man6677 3 years ago
Why are there no trades here ?

Thank you !

Great news today !
👍️0
newspopper newspopper 3 years ago
Get in KITL .08-.10 news will be poppin
👍️0
newspopper newspopper 3 years ago
Need more volume for Poppin action
👍️0
newspopper newspopper 3 years ago
Looking for FDA Poppin news
👍️0
newspopper newspopper 3 years ago
KITL news going to be poppin
👍️0
GOLDBUFFALO GOLDBUFFALO 3 years ago
Seems to be a very interesting stock.
👍️0

Your Recent History

USOTC
DTCFF
Defence Therapeutics (QB)
BIT
UC4PPK
Unicredit Bank
NASDAQ
FBYDW
Falcons Beyond Global
BOV
GOLL4Q
GOL PN
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads